Company Management

Sapreme Technologies BV

Biotechnology Research 1.01-1.07, Nl 14 employees

Employees: 14
Contacts: 4
Emails: 4
Phones: 1

sapreme-technologies.com LinkedIn Crunchbase

Sapreme Technologies BV Overview

Headquarters: 1.01-1.07, Nl
Website: sapreme-technologies.com
Industry: Biotechnology Research
Employees: 14
Founded: 2016
Funding: 17.3M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Sapreme Technologies BV

Sapreme’s mission is to develop next-generation macromolecule therapeutics by circumventing endosomal entrapment, thereby enhancing target engagement. The company’s proprietary endosomal escape platform improves the therapeutic window by enabling access to intracellular targets with minimal toxicity. This approach is applied for Sapreme’s internal pipeline and is available for partnering, without limitation to biologic modality or indication. Our solution to endosomal entrapment has the potential to re-open myriad drug development pathways for macromolecule therapeutics lacking efficacy and to explore new targets considered “undruggable” by permeabilizing endo-lysosomal membranes, allowing trapped macromolecules to be released, increasing target engagement without negatively impacting the plasma membrane integrity.

Sapreme Technologies BV Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Sapreme Technologies BV Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ruben Postel	Cso & Scientific Founder at Sapreme	Utrecht, Netherlands	Email Phone
Chris Huiskamp	SVP Business Operations	Breda, North Brabant, Netherlands	Email
Marco Timmers	Chief Executive Officer at Sapreme	Arnhem-nijmegen Region, Netherlands	Email
Karl Rothweiler	Aglaia Is an Early-stage Venture	De Bilt, Utrecht, Netherlands	Email